Given the pharmacological significance of 8-quinolinols and benzimidazoles, in the present paper, two series of new N-Heterocyclic having 8-quinolinol and benzimidazole moieties within a single molecular framework were prepared and characterized by elemental analysis, IR, and 13C/1H NMR techniques. To evaluate the desired compound as DNA-binder 3a, 3d, 7a, and 7d were docked with 1BNA DNA using AutoDock version 4.2. On the other hand, many proteins that are crystal structure of the BRCT repeat region from the breast cancer-associated protein, BRCA1 (ID: 1JNX), structure of a b-DNA dodecamer (ID: 1BNA), crystal structure of VEGFR kinase (liver cancer) protein (ID: 3WZE), and crystal structure of an allosteric Eya2 phosphatase inhibitor (lung cancer) protein versus (ID: 5ZMA) proteins, were used to compare the biological activities of all molecules using Maestro Molecular modeling platform. Afterward, ADME/T analysis of the molecules was performed. The derivatives of two series and Nitroxoline drugs were assessed for in vitro antibacterial activity against four microorganisms, including, two gram ⁺bacteria such as B. subtilis, S. aureus, and two gram ⁻bacteria such as E. ludwigii, E. coli. All derivatives were found to have moderate to good antibacterial potential. Of the 9 derivatives, 7d has significant antibacterial potential with MIC values of below 20 μg/mL comparable to Nitroxoline vs. all bacteria.

鉴于 8-羟基喹啉和苯并咪唑的药理意义，本文将两个系列的新N-在单个分子框架内具有 8-羟基喹啉和苯并咪唑部分的杂环被制备并通过元素分析、IR 和 13C/1H NMR 技术表征。为了评估作为 DNA 结合剂的所需化合物，使用 AutoDock 4.2 版将 3a、3d、7a 和 7d 与 1BNA DNA 对接。另一方面，许多蛋白质是乳腺癌相关蛋白 BRCA1 (ID: 1JNX) 的 BRCT 重复区域的晶体结构、b-DNA 十二聚体的结构 (ID: 1BNA)、VEGFR 激酶的晶体结构 (肝癌）蛋白（ID：3WZE），以及变构 Eya2 磷酸酶抑制剂（肺癌）蛋白与（ID：5ZMA）蛋白的晶体结构，用于使用 Maestro Molecular 建模平台比较所有分子的生物活性。然后，对分子进行 ADME/T 分析。⁺细菌，例如B. subtilis、S. aureus和两克^-细菌，例如E. ludwigii、E.coli。发现所有衍生物都具有中等至良好的抗菌潜力。在 9 种衍生物中，7d 具有显着的抗菌潜力，其 MIC 值低于 20 μg/mL，与所有细菌相比，与 Nitroxoline 相当。